Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -38.23% is 73% above its 5-year average of -139.73%, near the high end of its 5-year range (-4014.44%–-37.36%).
As of the fiscal period ended Tuesday, June 30, 2026. 69.54% above its 12-month average of -125.52%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -38.23%.
RETURN ON INVESTED CAPITAL (ROIC)
-38.23%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-125.52%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-841.19%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-139.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-73.28%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+69.54%
CURRENT VS 3Y AVG
+95.46%
CURRENT VS 5Y AVG
+72.64%
CURRENT VS 10Y AVG
+47.83%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 764 covered companies
CURRENT VS SECTOR MEDIAN
-11.02%
vs the sector median at left
Bio Green Med Solution, Inc.
Market Cap
$4.64M
Return on Invested Capital (ROIC)
-38.23%
TTM Avg
-125.52%
3Y Avg
-841.19%
5Y Avg
-139.73%
Market Cap
$4.82M
Return on Invested Capital (ROIC)
-122.56%
TTM Avg
-179.66%
3Y Avg
-275.36%
5Y Avg
-182.57%
Market Cap
$4.60M
Return on Invested Capital (ROIC)
-19.51%
TTM Avg
-11.65%
3Y Avg
-12.10%
5Y Avg
-17.92%
Market Cap
$4.52M
Return on Invested Capital (ROIC)
-246.61%
TTM Avg
-463.24%
3Y Avg
-303.42%
5Y Avg
-359.05%
Market Cap
$4.78M
Return on Invested Capital (ROIC)
-175.26%
TTM Avg
-258.55%
3Y Avg
-208.94%
5Y Avg
-173.09%
Market Cap
$4.34M
Return on Invested Capital (ROIC)
-221.32%
TTM Avg
-119.11%
3Y Avg
-77.97%
5Y Avg
-64.48%
Market Cap
$5.01M
Return on Invested Capital (ROIC)
-43.50%
TTM Avg
-54.16%
3Y Avg
-50.91%
5Y Avg
-58.12%
Market Cap
$5.04M
Return on Invested Capital (ROIC)
-126.69%
TTM Avg
-289.57%
3Y Avg
-198.60%
5Y Avg
-147.26%
Market Cap
$4.23M
Return on Invested Capital (ROIC)
-116.89%
TTM Avg
-117.72%
3Y Avg
-83.78%
5Y Avg
-61.46%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Bio Green Med Solution, Inc. (BGMS) | $4.64M | -38.23% | -125.52% | -841.19% | -139.73% |
| CalciMedica, Inc. (CALC)vs › | $4.82M | -122.56% | -179.66% | -275.36% | -182.57% |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.60M | -19.51% | -11.65% | -12.10% | -17.92% |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.52M | -246.61% | -463.24% | -303.42% | -359.05% |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.78M | -175.26% | -258.55% | -208.94% | -173.09% |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.34M | -221.32% | -119.11% | -77.97% | -64.48% |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.01M | -43.50% | -54.16% | -50.91% | -58.12% |
| Imunon, Inc. (IMNN)vs › | $5.04M | -126.69% | -289.57% | -198.60% | -147.26% |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.23M | -116.89% | -117.72% | -83.78% | -61.46% |
| GRI Bio, Inc. (GRI)vs › | $4.15M | N/A | -199.78% | -1598.70% | -1598.70% |
ROIC
-38.2%
ROE
-30.7%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -38.23% |
| 2026-03-31 | -53.74% |
| 2025-12-31 | -122.97% |
| 2025-09-30 | -128.19% |
| 2025-06-30 | -284.48% |
| 2025-03-31 | -413.06% |
| 2024-06-30 | -2343.53% |
| 2023-12-31 | -4014.44% |
| 2023-09-30 | -702.18% |
| 2023-06-30 | -311.06% |
| 2023-03-31 | -203.89% |
| 2022-12-31 | -142.44% |
| 2022-09-30 | -95.04% |
| 2022-06-30 | -82.04% |
| 2022-03-31 | -75.37% |
| 2021-12-31 | -60.80% |
| 2021-09-30 | -47.26% |
| 2021-06-30 | -37.36% |
| 2021-03-31 | -25.52% |
| 2020-12-31 | -30.99% |
| 2020-09-30 | -40.24% |
| 2020-06-30 | -36.29% |
| 2020-03-31 | -86.38% |
| 2019-12-31 | -75.13% |
| 2019-09-30 | -62.34% |
| 2019-06-30 | -55.77% |
| 2019-03-31 | -50.41% |
| 2018-12-31 | -62.11% |
| 2018-09-30 | -55.56% |
| 2018-06-30 | -47.70% |
| 2018-03-31 | -43.67% |
| 2017-12-31 | -43.36% |
| 2017-09-30 | -44.36% |
| 2017-06-30 | -100.54% |
| 2017-03-31 | -101.19% |
| 2016-12-31 | -98.24% |
| 2016-09-30 | -86.89% |
| 2016-06-30 | -110.87% |
| 2016-03-31 | -90.98% |
| 2015-12-31 | -85.06% |
| 2015-09-30 | -83.04% |
